Clinical Trials Directory

Trials / Completed

CompletedNCT04024020

Chronic Insomnia and CSF Markers of Dementia

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
30 Years – 50 Years
Healthy volunteers

Summary

The longstanding view has been that insomnia, and other forms of sleep disturbance, emerge as a consequence of dementia and are the result of progressive neuronal damage. However, there is growing evidence that the direction of causation may go both ways, with sleep disturbance potentially increasing vulnerability to dementia. Longitudinal studies have found that sleep disturbance often precedes and increases risk for dementia by several years.The purpose of this study is to examine the relationship between chronic insomnia and dementia biomarkers and orexin levels found in cerebrospinal fluid (CSF). Fifteen adults age 30-50 with chronic insomnia and age- and gender-matched good sleepers will undergo overnight polysomnography and CSF sampling in the morning.

Conditions

Interventions

TypeNameDescription
OTHERlumbar punctureSubjects will have a lumbar puncture to collect cerebrospinal fluid collection

Timeline

Start date
2019-01-01
Primary completion
2023-10-31
Completion
2023-10-31
First posted
2019-07-18
Last updated
2025-01-23
Results posted
2025-01-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04024020. Inclusion in this directory is not an endorsement.

Chronic Insomnia and CSF Markers of Dementia (NCT04024020) · Clinical Trials Directory